National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research

National Health Investors, Inc. (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Several other research analysts also recently weighed in on NHI. BidaskClub downgraded shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. ValuEngine raised shares of National Health Investors from a “hold” rating to a “buy” rating in a research note on Friday, November 10th. Mizuho reaffirmed a “hold” rating and set a $82.00 price objective on shares of National Health Investors in a research note on Wednesday, October 4th. BMO Capital Markets reaffirmed a “hold” rating and set a $80.00 price objective on shares of National Health Investors in a research note on Wednesday, October 18th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $82.00 price objective on shares of National Health Investors in a research note on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $80.14.

National Health Investors (NYSE NHI) opened at $77.80 on Friday. National Health Investors has a 1 year low of $68.75 and a 1 year high of $81.21. The company has a debt-to-equity ratio of 0.84, a quick ratio of 12.72 and a current ratio of 12.72. The firm has a market cap of $3,271.07, a PE ratio of 15.12, a P/E/G ratio of 3.90 and a beta of 0.58.

TRADEMARK VIOLATION NOTICE: “National Health Investors, Inc. (NHI) Downgraded by Zacks Investment Research” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://transcriptdaily.com/2017/11/17/national-health-investors-inc-nhi-downgraded-by-zacks-investment-research.html.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 5.19% of the company’s stock.

Several institutional investors have recently bought and sold shares of NHI. BlackRock Inc. grew its stake in shares of National Health Investors by 6.6% in the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock valued at $280,927,000 after buying an additional 218,482 shares during the period. Allianz Asset Management GmbH grew its stake in shares of National Health Investors by 57.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock valued at $30,514,000 after buying an additional 144,650 shares during the period. State Street Corp grew its stake in shares of National Health Investors by 8.5% in the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock valued at $79,133,000 after buying an additional 78,355 shares during the period. Vanguard Group Inc. grew its stake in shares of National Health Investors by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock valued at $498,323,000 after buying an additional 72,518 shares during the period. Finally, Renaissance Technologies LLC purchased a new stake in shares of National Health Investors in the 1st quarter valued at approximately $4,796,000. 70.14% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply